<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34236922</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>27</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1744-7631</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>6</Issue><PubDate><Year>2021</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Expert opinion on therapeutic targets</Title><ISOAbbreviation>Expert Opin Ther Targets</ISOAbbreviation></Journal><ArticleTitle>Drugs that offer the potential to reduce hospitalization and mortality from SARS-CoV-2 infection: The possible role of the sigma-1 receptor and autophagy.</ArticleTitle><Pagination><StartPage>435</StartPage><EndPage>449</EndPage><MedlinePgn>435-449</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/14728222.2021.1952987</ELocationID><Abstract><AbstractText><b>Introduction</b>: Despite the availability of new vaccines for SARS-CoV-2, there has been slow uptake and problems with supply in some parts of the world. Hence, there is still a necessity for drugs that can prevent hospitalization of patients and reduce the strain on health care systems. Drugs with sigma affinity potentially provide protection against the most severe symptoms of SARS-COV-2 and could prevent mortality via interactions with the sigma-1 receptor.<b>Areas covered</b>: This review examines the role of the sigma-1 receptor and autophagy in SARS-CoV-2 infections and how they may be linked. The authors reveal how sigma ligands may reduce the symptoms, complications, and deaths resulting from SARS-CoV-2 and offer insights on those patient cohorts that may benefit most from these drugs.<b>Expert opinion</b>: Drugs with sigma affinity potentially offer protection against the most severe symptoms of SARS-CoV-2 via interactions with the sigma-1 receptor. Agonists of the sigma-1 receptor may provide protection of the mitochondria, activate mitophagy to remove damaged and leaking mitochondria, prevent ER stress, manage calcium ion transport, and induce autophagy to prevent cell death in response to infection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Brimson</LastName><ForeName>James Michael</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0000-0003-2074-8262</Identifier><AffiliationInfo><Affiliation>Natural Products for Neuroprotection and Anti-ageing Research Unit, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Chemistry, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prasanth</LastName><ForeName>Mani Iyer</ForeName><Initials>MI</Initials><Identifier Source="ORCID">0000-0003-0956-0410</Identifier><AffiliationInfo><Affiliation>Natural Products for Neuroprotection and Anti-ageing Research Unit, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Chemistry, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malar</LastName><ForeName>Dicson Sheeja</ForeName><Initials>DS</Initials><Identifier Source="ORCID">0000-0003-4253-9496</Identifier><AffiliationInfo><Affiliation>Natural Products for Neuroprotection and Anti-ageing Research Unit, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Chemistry, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brimson</LastName><ForeName>Sirikalaya</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-3593-2601</Identifier><AffiliationInfo><Affiliation>Department of Clinical Microscopy, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thitilertdecha</LastName><ForeName>Premrutai</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-1853-4073</Identifier><AffiliationInfo><Affiliation>Siriraj Research Group in Immunobiology and Therapeutic Sciences, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tencomnao</LastName><ForeName>Tewin</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-4177-2165</Identifier><AffiliationInfo><Affiliation>Natural Products for Neuroprotection and Anti-ageing Research Unit, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Chemistry, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Expert Opin Ther Targets</MedlineTA><NlmUniqueID>101127833</NlmUniqueID><ISSNLinking>1472-8222</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017480">Receptors, sigma</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001343" MajorTopicYN="Y">Autophagy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017480" MajorTopicYN="N">Receptors, sigma</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000093485" MajorTopicYN="Y">COVID-19 Drug Treatment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000097605" MajorTopicYN="N">Sigma-1 Receptor</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">autophagy</Keyword><Keyword MajorTopicYN="N">chlorpromazine</Keyword><Keyword MajorTopicYN="N">critical care</Keyword><Keyword MajorTopicYN="N">donepezil</Keyword><Keyword MajorTopicYN="N">fluoxetine</Keyword><Keyword MajorTopicYN="N">fluvoxamine</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">sigma-1</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>8</Day><Hour>17</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>7</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34236922</ArticleId><ArticleId IdType="pmc">PMC8290373</ArticleId><ArticleId IdType="doi">10.1080/14728222.2021.1952987</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dodds K, Broto VC, Detterbeck K, et al. The COVID-19 pandemic: territorial, political and governance dimensions of the crisis. Territory, Politics, Governance. 2020. May 26;8(3):289&#x2013;298.</Citation></Reference><Reference><Citation>Ellul MA, Benjamin L, Singh B, et al. Neurological associations of COVID-19. Lancet Neurol. 2020. September 01;19(9):767&#x2013;783.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7332267</ArticleId><ArticleId IdType="pubmed">32622375</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg RK, Paliwal VK, Gupta A.. Encephalopathy in patients with COVID-19: a review. J Med Virol. 2021;93(1):206&#x2013;222.</Citation><ArticleIdList><ArticleId IdType="pubmed">32558956</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan L, Lin ZC, Ray J, et al. Neurological implications of COVID-19: a review of the science and clinical guidance. BMJ Neurol Open. 2020;2(2):e000101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7871721</ArticleId><ArticleId IdType="pubmed">33681805</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Geddes JR, Husain M, et al. 66-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8(5): 416&#x2013;427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Paterson RW, Brown RL, Benjamin L, et al. The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain. 2020;143(10):3104&#x2013;3120.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454352</ArticleId><ArticleId IdType="pubmed">32637987</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghannam M, Alshaer Q, Al-Chalabi M, et al. Neurological involvement of coronavirus disease 2019: a systematic review. J Neurol. 2020. November 01;267(11):3135&#x2013;3153.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7304377</ArticleId><ArticleId IdType="pubmed">32561990</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Li M, Wang M, et al. Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. Stroke Vasc Neurol. 2020;5(3):279&#x2013;284.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7371480</ArticleId><ArticleId IdType="pubmed">32616524</ArticleId></ArticleIdList></Reference><Reference><Citation>Oxley TJ, Mocco J, Majidi S, et al. Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med. 2020;382(20):e60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7207073</ArticleId><ArticleId IdType="pubmed">32343504</ArticleId></ArticleIdList></Reference><Reference><Citation>Moro E, Priori A, Beghi E, et al. The international European academy of neurology survey on neurological symptoms in patients with COVID-19 infection. Eur J Neurol. 2020;27(9):1727&#x2013;1737.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7323212</ArticleId><ArticleId IdType="pubmed">32558002</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam MH-B, Wing Y-K, Yu -MW-M, et al. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch Internal Med. 2009;169(22):2142&#x2013;2147.</Citation><ArticleIdList><ArticleId IdType="pubmed">20008700</ArticleId></ArticleIdList></Reference><Reference><Citation>Baxendale IR, Hayward JJ, Ley SV, et al. Pharmaceutical strategy and innovation: an academics perspective. ChemMedChem. 2007;2(6):768&#x2013;788.</Citation><ArticleIdList><ArticleId IdType="pubmed">17458911</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoertel N, S&#xe1;nchez-Rico M, Vernet R, et al. Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study. Mol Psychiatry. 2021. DOI:10.1038/s41380-021-01021-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-021-01021-4</ArticleId><ArticleId IdType="pubmed">33536545</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang T, Bidon M, Jaimes JA, et al. Coronavirus membrane fusion mechanism offers a potential target for antiviral development. Antiviral Res. 2020;178:104792.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7194977</ArticleId><ArticleId IdType="pubmed">32272173</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Yang P, Liu K, et al. SARS coronavirus entry into host cells through a novel clathrin-and caveolae-independent endocytic pathway. Cell Res. 2008;18(2):290&#x2013;301.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7091891</ArticleId><ArticleId IdType="pubmed">18227861</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang T, Jaimes JA, Bidon MK, et al. Proteolytic activation of SARS-CoV-2 spike at the S1/S2 boundary: potential role of proteases beyond furin. ACS Infect Dis. 2021;7(2):264&#x2013;272.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7839419</ArticleId><ArticleId IdType="pubmed">33432808</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawase M, Shirato K, van der Hoek L, et al. Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry. J Virol. 2012;86(12):6537&#x2013;6545.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3393535</ArticleId><ArticleId IdType="pubmed">22496216</ArticleId></ArticleIdList></Reference><Reference><Citation>He B. Viruses, endoplasmic reticulum stress, and interferon responses. Cell Death Differ. 2006;13(3):393&#x2013;403.</Citation><ArticleIdList><ArticleId IdType="pubmed">16397582</ArticleId></ArticleIdList></Reference><Reference><Citation>Hetz CA, Soto C. Stressing out the ER: a role of the unfolded protein response in prion-related disorders. Curr Mol Med. 2006;6(1):37&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2838391</ArticleId><ArticleId IdType="pubmed">16472111</ArticleId></ArticleIdList></Reference><Reference><Citation>Sano R, Reed JC. ER stress-induced cell death mechanisms. Biochim Biophys Acta-Mol Cell Res. 2013;1833(12):3460&#x2013;3470.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3834229</ArticleId><ArticleId IdType="pubmed">23850759</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;seler A, Sabirli R, G&#xf6;ren T, et al. Endoplasmic reticulum stress markers in SARS-COV-2 infection and pneumonia: case-control study. in vivo. 2020;34(3 suppl):1645&#x2013;1650.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8378033</ArticleId><ArticleId IdType="pubmed">32503824</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartoszewski R, Dabrowski M, Jakiela B, et al. SARS-CoV-2 may regulate cellular responses through depletion of specific host miRNAs. Am J Physiol Lung Cell Mol Physiol. 2020;319(3):L444&#x2013;L455.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7473886</ArticleId><ArticleId IdType="pubmed">32755307</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng S, Wang J, Wei S, et al. Endogenous cellular microRNAs mediate antiviral defense against influenza A virus. Mol Ther Nucleic Acids. 2018;10:361&#x2013;375.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5862538</ArticleId><ArticleId IdType="pubmed">29499948</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsitsiou E, Lindsay MA. microRNAs and the immune response. Curr Opin Pharmacol. 2009;9(4):514&#x2013;520.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2742742</ArticleId><ArticleId IdType="pubmed">19525145</ArticleId></ArticleIdList></Reference><Reference><Citation>Gebert M, Bartoszewska S, Janaszak-Jasiecka A, et al. PIWI proteins contribute to apoptosis during the UPR in human airway epithelial cells. Sci Rep. 2018;8(1):1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6219583</ArticleId><ArticleId IdType="pubmed">30401887</ArticleId></ArticleIdList></Reference><Reference><Citation>Morishita H, Mizushima N. Diverse cellular roles of autophagy. Annu Rev Cell Dev Biol. 2019;35(1):453&#x2013;475.</Citation><ArticleIdList><ArticleId IdType="pubmed">31283377</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Matrenec R, Gack MU, et al. Disassembly of the TRIM23-TBK1 complex by the Us11 protein of herpes simplex virus 1 impairs autophagy. J Virol. 2019;93(17). DOI:10.1128/JVI.00497-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00497-19</ArticleId><ArticleId IdType="pmc">PMC6694819</ArticleId><ArticleId IdType="pubmed">31189704</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian L, Yang Y, Li C, et al. The cytotoxicity of coxsackievirus B3 is associated with a blockage of autophagic flux mediated by reduced syntaxin 17 expression. Cell Death Dis. 2018;9(2):1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5833838</ArticleId><ArticleId IdType="pubmed">29445155</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaumorcel M, Lussignol M, Mouna L, et al. The human cytomegalovirus protein TRS1 inhibits autophagy via its interaction with Beclin 1. J Virol. 2012;86(5):2571&#x2013;2584.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3302257</ArticleId><ArticleId IdType="pubmed">22205736</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruno AP, De Simone FI, Iorio V, et al. HIV-1 Tat protein induces glial cell autophagy through enhancement of BAG3 protein levels. Cell Cycle. 2014;13(23):3640&#x2013;3644.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4614156</ArticleId><ArticleId IdType="pubmed">25483098</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeganeh B, Ghavami S, Rahim MN, et al. Autophagy activation is required for influenza A virus-induced apoptosis and replication. Biochim Biophys Acta-Mol Cell Res. 2018;1865(2):364&#x2013;378.</Citation><ArticleIdList><ArticleId IdType="pubmed">29108912</ArticleId></ArticleIdList></Reference><Reference><Citation>Ait-Goughoulte M, Kanda T, Meyer K, et al. Hepatitis C virus genotype 1a growth and induction of autophagy. J Virol. 2008;82(5):2241&#x2013;2249.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2258951</ArticleId><ArticleId IdType="pubmed">18077704</ArticleId></ArticleIdList></Reference><Reference><Citation>Gassen NC, Papies J, Bajaj T, et al. SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targeting antivirals. Nature Communications. 2021;12(1):3818.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8217552</ArticleId><ArticleId IdType="pubmed">34155207</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh K, Chen Y-C, Hassanzadeh S, et al. Network analysis and transcriptome profiling identify autophagic and mitochondrial dysfunctions in SARS-CoV-2 infection. Front Genet. 2021;12:289.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8008150</ArticleId><ArticleId IdType="pubmed">33796130</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu Y, Wang X, Zhu Y, et al. ORF3a mediated-incomplete autophagy facilitates SARS-CoV-2 replication. Preprint;2020. doi:10.1101/2020.11.12.380709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.11.12.380709</ArticleId><ArticleId IdType="pmc">PMC8353283</ArticleId><ArticleId IdType="pubmed">34386498</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang P, Nishimura T, Sakamaki Y, et al. The HOPS complex mediates autophagosome&#x2013;lysosome fusion through interaction with syntaxin 17. Mol Biol Cell. 2014;25(8):1327&#x2013;1337.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3982997</ArticleId><ArticleId IdType="pubmed">24554770</ArticleId></ArticleIdList></Reference><Reference><Citation>Miao G, Zhao H, Li Y, et al. ORF3a of the COVID-19 virus SARS-CoV-2 blocks HOPS complex-mediated assembly of the SNARE complex required for autolysosome formation. Dev Cell. 2021;56(4):427&#x2013;442. e5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7832235</ArticleId><ArticleId IdType="pubmed">33422265</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu S, He Y, Qiu X, et al. Targeting the potent Beclin 1&#x2013;UVRAG coiled-coil interaction with designed peptides enhances autophagy and endolysosomal trafficking. Proc Nat Acad Sci. 2018;115(25):E5669&#x2013;E5678.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6016778</ArticleId><ArticleId IdType="pubmed">29866835</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuen CK, Wong WM, Mak LF, et al. Suppression of SARS&#x2010;CoV&#x2010;2 infection in ex&#x2010;vivo human lung tissues by targeting class III phosphoinositide 3&#x2010;kinase. J Med Virol. 2021;93(4):2076&#x2013;2083.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7675438</ArticleId><ArticleId IdType="pubmed">33026649</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorshkov K, Chen CZ, Bostwick R, et al. The SARS-CoV-2 Cytopathic Effect Is Blocked by Lysosome Alkalizing Small Molecules. ACS Infectious Diseases. 2021;7(6):1389&#x2013;1408.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7771250</ArticleId><ArticleId IdType="pubmed">33346633</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H, Shen H, Li J, et al. Sigma-1 receptor ablation impairs autophagosome clearance. Autophagy. 2019;15(8):1492.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6693456</ArticleId><ArticleId IdType="pubmed">30871407</ArticleId></ArticleIdList></Reference><Reference><Citation>Christ MG, Huesmann H, Nagel H, et al. Sigma-1 receptor activation induces autophagy and increases proteostasis capacity in vitro and in vivo. Cells. 2019;8(3):211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6468724</ArticleId><ArticleId IdType="pubmed">30832324</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeon S-H, Kim SH, Kim Y, et al. The tricyclic antidepressant imipramine induces autophagic cell death in U-87MG glioma cells. Biochem Biophys Res Commun. 2011;413(2):311&#x2013;317.</Citation><ArticleIdList><ArticleId IdType="pubmed">21889492</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J-R, Xu H-Z, Nie S, et al. Fluoxetine-enhanced autophagy ameliorates early brain injury via inhibition of NLRP3 inflammasome activation following subarachnoid hemorrhage in rats. J Neuroinflammation. 2017;14(1):1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5598033</ArticleId><ArticleId IdType="pubmed">28903766</ArticleId></ArticleIdList></Reference><Reference><Citation>Shu X, Sun Y, Sun X, et al. The effect of fluoxetine on astrocyte autophagy flux and injured mitochondria clearance in a mouse model of depression. Cell Death Dis. 2019;10(8):1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6675792</ArticleId><ArticleId IdType="pubmed">31371719</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho YS, Yen C-N, Shim JS, et al. Antidepressant indatraline induces autophagy and inhibits restenosis via suppression of mTOR/S6 kinase signaling pathway. Sci Rep. 2016;6(1):34655.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5046148</ArticleId><ArticleId IdType="pubmed">27694974</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Li L. Targeting autophagy for the treatment of Alzheimer&#x2019;s disease: challenges and opportunities. Front Mol Neurosci. 2019;12:203.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6713911</ArticleId><ArticleId IdType="pubmed">31507373</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasanth MI, Malar D, Tencomnao T, et al. The emerging role of the sigma-1 receptor in autophagy: hand-in-hand targets for the treatment of Alzheimer&#x2019;s disease. Expert Opinion on Therapeutic Targets. 2021; Online ahead of print; doi.10.1080/14728222.2021.1939681</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14728222.2021.1939681</ArticleId><ArticleId IdType="pubmed">34110944</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu J, Li M, Li D, et al. Stimulation of sigma-1 receptor protects against cardiac fibrosis by alleviating IRE1 pathway and autophagy impairment. Oxid Med Cell Longev. 2021. Jan:8836818. DOI:10.1155/2021/8836818</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/8836818</ArticleId><ArticleId IdType="pmc">PMC7801073</ArticleId><ArticleId IdType="pubmed">33488945</ArticleId></ArticleIdList></Reference><Reference><Citation>Kourrich S, Su T-P, Fujimoto M, et al. The sigma-1 receptor: roles in neuronal plasticity and disease. Trends Neurosci. 2012;35(12):762&#x2013;771.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3587126</ArticleId><ArticleId IdType="pubmed">23102998</ArticleId></ArticleIdList></Reference><Reference><Citation>Morales-L&#xe1;zaro SL, Gonz&#xe1;lez-Ram&#xed;rez R, Rosenbaum T. Molecular interplay between the sigma-1 receptor, steroids, and ion channels. Front Pharmacol. 2019;10:419.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6491805</ArticleId><ArticleId IdType="pubmed">31068816</ArticleId></ArticleIdList></Reference><Reference><Citation>Tchedre KT, Huang R-Q, Dibas A, et al. Sigma-1 receptor regulation of voltage-gated calcium channels involves a direct interaction. Invest Ophthalmol Vis Sci. 2008;49(11):4993&#x2013;5002.</Citation><ArticleIdList><ArticleId IdType="pubmed">18641291</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinoshita M, Matsuoka Y, Suzuki T, et al. Sigma-1 receptor alters the kinetics of Kv1. 3 voltage gated potassium channels but not the sensitivity to receptor ligands. Brain Res. 2012;1452:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3670091</ArticleId><ArticleId IdType="pubmed">22433979</ArticleId></ArticleIdList></Reference><Reference><Citation>Brimson J, Brown C, Safrany S. Antagonists show GTP-sensitive high affinity binding to the sigma-1 receptor. Br J Pharmacol. 2011;164(2b):772&#x2013;780.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3188898</ArticleId><ArticleId IdType="pubmed">21486275</ArticleId></ArticleIdList></Reference><Reference><Citation>Ueda H, Yoshida A, Tokuyama S, et al. Neurosteroids stimulate G protein-coupled sigma receptors in mouse brain synaptic membrane. Neurosci Res. 2001;41(1):33&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">11535291</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi T. The sigma-1 receptor in cellular stress signaling [mini review]. Front Neurosci. 2019. July 16;13(733). DOI:10.3389/fnins.2019.00733.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00733</ArticleId><ArticleId IdType="pmc">PMC6646578</ArticleId><ArticleId IdType="pubmed">31379486</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng T-Y, Tsai S-YA, Su T-P. Roles of sigma-1 receptors on mitochondrial functions relevant to neurodegenerative diseases. J Biomed Sci. 2017;24(1):1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5603014</ArticleId><ArticleId IdType="pubmed">28917260</ArticleId></ArticleIdList></Reference><Reference><Citation>Brimson JM, Safrany ST, Qassam H, et al. Dipentylammonium binds to the sigma-1 receptor and protects against glutamate toxicity, attenuates dopamine toxicity and potentiates neurite outgrowth in various cultured cell lines. Neurotox Res. 2018;34(2):263&#x2013;272.</Citation><ArticleIdList><ArticleId IdType="pubmed">29589276</ArticleId></ArticleIdList></Reference><Reference><Citation>Brimson JM, Akula KK, Abbas H, et al. Simple ammonium salts acting on sigma-1 receptors yield potential treatments for cancer and depression. Sci Rep. 2020;10(1):9251.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7280195</ArticleId><ArticleId IdType="pubmed">32514120</ArticleId></ArticleIdList></Reference><Reference><Citation>Brimson JM, Brimson S, Chomchoei C, et al. Using Sigma-ligands as part of a multi-receptor approach to target diseases of the brain. Expert Opin Ther Targets. 2020;24(10):1009&#x2013;1028.</Citation><ArticleIdList><ArticleId IdType="pubmed">32746649</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon DE, Jang GM, Bouhaddou M, et al. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature. 2020;583(7816): 459&#x2013;468.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7431030</ArticleId><ArticleId IdType="pubmed">32353859</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon DE, Hiatt J, Bouhaddou M, et al. Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. Science (New York, NY). 2020;370(6521): eabe9403.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7808408</ArticleId><ArticleId IdType="pubmed">33060197</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehrer S, Rheinstein PH. Homozygosity for rs17775810 Minor Allele associated with reduced mortality of COVID-19 in the UK Biobank Cohort. in vivo. 2021;35(2):965&#x2013;968.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8045077</ArticleId><ArticleId IdType="pubmed">33622890</ArticleId></ArticleIdList></Reference><Reference><Citation>Gassen NC, Niemeyer D, Muth D, et al. SKP2 attenuates autophagy through Beclin1-ubiquitination and its inhibition reduces MERS-Coronavirus infection. Nat Commun. 2019;10(1):1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6920372</ArticleId><ArticleId IdType="pubmed">31852899</ArticleId></ArticleIdList></Reference><Reference><Citation>Jheng J-R, Ho J-Y, Horng J-T. ER stress, autophagy, and RNA viruses. Front Microbiol. 2014;5:388.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4122171</ArticleId><ArticleId IdType="pubmed">25140166</ArticleId></ArticleIdList></Reference><Reference><Citation>Aweya JJ, Mak TM, Lim SG, et al. The p7 protein of the hepatitis C virus induces cell death differently from the influenza A virus viroporin M2. Virus Res. 2013;172(1&#x2013;2):24&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7114515</ArticleId><ArticleId IdType="pubmed">23246447</ArticleId></ArticleIdList></Reference><Reference><Citation>Shrivastava S, Bhanja Chowdhury J, Steele R, et al. Hepatitis C virus upregulates Beclin1 for induction of autophagy and activates mTOR signaling. J Virol. 2012;86(16):8705&#x2013;8712.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3421755</ArticleId><ArticleId IdType="pubmed">22674982</ArticleId></ArticleIdList></Reference><Reference><Citation>Dreux M, Gastaminza P, Wieland SF, et al. The autophagy machinery is required to initiate hepatitis C virus replication. Proc Nat Acad Sci. 2009;106(33):14046&#x2013;14051.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2729017</ArticleId><ArticleId IdType="pubmed">19666601</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Zheng T, Lin L, et al. Influenza A virus induces autophagy by its hemagglutinin binding to cell surface heat shock protein 90AA1. Front Microbiol. 2020;11:2399.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7575715</ArticleId><ArticleId IdType="pubmed">33117314</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang Q, Luo Z, Zeng J, et al. Zika virus NS4A and NS4B proteins deregulate Akt-mTOR signaling in human fetal neural stem cells to inhibit neurogenesis and induce autophagy. Cell Stem Cell. 2016;19(5):663&#x2013;671.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5144538</ArticleId><ArticleId IdType="pubmed">27524440</ArticleId></ArticleIdList></Reference><Reference><Citation>Friesland M, Mingorance L, Chung J, et al. Sigma-1 receptor regulates early steps of viral RNA replication at the onset of hepatitis C virus infection. J Virol. 2013;87(11):6377&#x2013;6390.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3648129</ArticleId><ArticleId IdType="pubmed">23536676</ArticleId></ArticleIdList></Reference><Reference><Citation>Gekker G, Hu S, Sheng WS, et al. Cocaine-induced HIV-1 expression in microglia involves sigma-1 receptors and transforming growth factor-&#x3b2;1. Int Immunopharmacol. 2006. June 01;6(6):1029&#x2013;1033.</Citation><ArticleIdList><ArticleId IdType="pubmed">16644490</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez OV, Gorantla S, Segarra AC, et al. Sigma-1 receptor antagonist (BD1047) decreases Cathepsin B secretion in HIV-infected macrophages exposed to cocaine. J Neuroimmune Pharmacol. 2019. June 01;14(2):226&#x2013;240.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6488453</ArticleId><ArticleId IdType="pubmed">30306495</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiryaev SA, Mesci P, Pinto A, et al. Repurposing of the anti-malaria drug chloroquine for Zika Virus treatment and prophylaxis. Sci Rep. 2017;7(1):1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5694003</ArticleId><ArticleId IdType="pubmed">29150641</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A, Liang B, Aarthy M, et al. Hydroxychloroquine inhibits Zika virus NS2B-NS3 protease. ACS Omega. 2018;3(12):18132&#x2013;18141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6312647</ArticleId><ArticleId IdType="pubmed">30613818</ArticleId></ArticleIdList></Reference><Reference><Citation>de Souza AAA, Torres LR, Capobianco LRPL, et al. Chloroquine and sulfadoxine derivatives inhibit ZIKV replication in cervical cells. Viruses. 2021;13(1):36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7823661</ArticleId><ArticleId IdType="pubmed">33383619</ArticleId></ArticleIdList></Reference><Reference><Citation>Savarino A, Boelaert JR, Cassone A, et al. Effects of chloroquine on viral infections: an old drug against today&#x2019;s diseases. Lancet Infect Dis. 2003;3(11):722&#x2013;727.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7128816</ArticleId><ArticleId IdType="pubmed">14592603</ArticleId></ArticleIdList></Reference><Reference><Citation>Peymani P, Yeganeh B, Sabour S, et al. New use of an old drug: chloroquine reduces viral and ALT levels in HCV non-responders (a randomized, triple-blind, placebo-controlled pilot trial). Can J Physiol Pharmacol. 2016;94(6):613&#x2013;619.</Citation><ArticleIdList><ArticleId IdType="pubmed">26998724</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizui T, Yamashina S, Tanida I, et al. Inhibition of hepatitis C virus replication by chloroquine targeting virus-associated autophagy. J Gastroenterol. 2010;45(2):195&#x2013;203.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7088329</ArticleId><ArticleId IdType="pubmed">19760134</ArticleId></ArticleIdList></Reference><Reference><Citation>Dyall J, Coleman CM, Venkataraman T, et al. Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection. Antimicrob Agents Chemother. 2014;58(8):4885&#x2013;4893.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4136000</ArticleId><ArticleId IdType="pubmed">24841273</ArticleId></ArticleIdList></Reference><Reference><Citation>Inoue Y, Tanaka N, Tanaka Y, et al. Clathrin-dependent entry of severe acute respiratory syndrome coronavirus into target cells expressing ACE2 with the cytoplasmic tail deleted. J Virol. 2007;81(16):8722&#x2013;8729.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1951348</ArticleId><ArticleId IdType="pubmed">17522231</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, Xia S, Sun Z, et al. Testing of Middle East respiratory syndrome coronavirus replication inhibitors for the ability to block viral entry. Antimicrob Agents Chemother. 2015;59(1):742&#x2013;744.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4291393</ArticleId><ArticleId IdType="pubmed">25331705</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunes-Correia I, Eul&#xe1;lio A, Nir S, et al. Caveolae as an additional route for influenza virus endocytosis in MDCK cells. Cell Mol Biol Lett. 2004;9(1):47&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">15048150</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo J, Quinn KK, Kye S, et al. Fluoxetine is a potent inhibitor of coxsackievirus replication. Antimicrob Agents Chemother. 2012;56(9):4838&#x2013;4844.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3421851</ArticleId><ArticleId IdType="pubmed">22751539</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer L, Manganaro R, Zonsics B, et al. Fluoxetine inhibits enterovirus replication by targeting the viral 2C protein in a stereospecific manner. ACS Infect Dis. 2019;5(9):1609&#x2013;1623.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6747591</ArticleId><ArticleId IdType="pubmed">31305993</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DA, Seki SM, Fern&#xe1;ndez-Casta&#xf1;eda A, et al. Modulation of the sigma-1 receptor&#x2013;IRE1 pathway is beneficial in preclinical models of inflammation and sepsis. Sci Transl Med. 2019;11(478):eaau5266.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6936250</ArticleId><ArticleId IdType="pubmed">30728287</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenze EJ, Mattar C, Zorumski CF, et al. Fluvoxamine vs Placebo and clinical deterioration in outpatients with symptomatic COVID-19: a randomized clinical trial. JAMA. 2020;324(22): 2292&#x2013;2300.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7662481</ArticleId><ArticleId IdType="pubmed">33180097</ArticleId></ArticleIdList></Reference><Reference><Citation>Seftel D, Boulware DR. Prospective cohort of fluvoxamine for early treatment of Coronavirus disease 19. Open Forum Infect Dis. 2021. Feb 8;8(2):ofab050.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7888564</ArticleId><ArticleId IdType="pubmed">33623808</ArticleId></ArticleIdList></Reference><Reference><Citation>Knoops K, Kikkert M, Van Den Worm SH, et al. SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum. PLoS Biol. 2008;6(9):e226.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2535663</ArticleId><ArticleId IdType="pubmed">18798692</ArticleId></ArticleIdList></Reference><Reference><Citation>Maier HJ, Hawes PC, Cottam EM, et al. Infectious bronchitis virus generates spherules from zippered endoplasmic reticulum membranes. MBio. 2013;4(5). DOI:10.1128/mBio.00801-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.00801-13</ArticleId><ArticleId IdType="pmc">PMC3812713</ArticleId><ArticleId IdType="pubmed">24149513</ArticleId></ArticleIdList></Reference><Reference><Citation>Reggiori F, Monastyrska I, Verheije MH, et al. Coronaviruses Hijack the LC3-I-positive EDEMosomes, ER-derived vesicles exporting short-lived ERAD regulators, for replication. Cell Host Microbe. 2010;7(6):500&#x2013;508.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7103375</ArticleId><ArticleId IdType="pubmed">20542253</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung TS, Liu DX. The ER stress sensor IRE1 and MAP kinase ERK modulate autophagy induction in cells infected with coronavirus infectious bronchitis virus. Virology. 2019. Jul;533:34&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7112053</ArticleId><ArticleId IdType="pubmed">31082732</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung TS, Liu DX. Coronavirus infection, ER stress, apoptosis and innate immunity. Front Microbiol. 2014;5:296.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4060729</ArticleId><ArticleId IdType="pubmed">24987391</ArticleId></ArticleIdList></Reference><Reference><Citation>Song P, Li W, Xie J, et al. Cytokine storm induced by SARS-CoV-2. Clin Chim Acta. 2020;509:280&#x2013;287.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7283076</ArticleId><ArticleId IdType="pubmed">32531256</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen SF, Ho Y-C. SARS-CoV-2: a storm is raging. J Clin Invest. 2020;130(5):2202&#x2013;2205.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7190904</ArticleId><ArticleId IdType="pubmed">32217834</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xe4;rtter S, Gr&#xf6;zinger M, Weigmann H, et al. Increased bioavailability of oral melatonin after fluvoxamine coadministration. Clin Pharmacol Ther. 2000;67(1):1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">10668847</ArticleId></ArticleIdList></Reference><Reference><Citation>Demisch K, Demisch L, Bochnik HJ, et al. Melatonin and cortisol increase after fluvoxamine. Br J Clin Pharmacol. 1986;22(5):620&#x2013;622.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1401188</ArticleId><ArticleId IdType="pubmed">3098271</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson GM. Fluvoxamine, melatonin and COVID-19. Psychopharmacology (Berl). 2021. February 01;238(2):611.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7779245</ArticleId><ArticleId IdType="pubmed">33392622</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandi-Perumal SR, Cardinali DP, Reiter RJ, et al. Low melatonin as a contributor to SARS-CoV-2 disease. Melatonin Res. 2020;3(4):558&#x2013;576.</Citation></Reference><Reference><Citation>Tesarik J. Melatonin attenuates growth factor receptor signaling required for SARS-CoV-2 replication. Melatonin Res. 2020;3(4):534&#x2013;537.</Citation></Reference><Reference><Citation>Boga JA, Coto-Montes A. ER stress and autophagy induced by SARS-CoV-2: the targets for melatonin treatment. Melatonin Res. 2020;3(3):346&#x2013;361.</Citation></Reference><Reference><Citation>Singh KK, Chaubey G, Chen JY, et al. Decoding SARS-CoV-2 hijacking of host mitochondria in COVID-19 pathogenesis. Am J Physiol Cell Physiol. 2020;319(2):C258&#x2013;C267.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7381712</ArticleId><ArticleId IdType="pubmed">32510973</ArticleId></ArticleIdList></Reference><Reference><Citation>Gatti P, Ilamathi HS, Todkar K, et al. Mitochondria targeted viral replication and survival strategies&#x2014;prospective on SARS-CoV-2. Front Pharmacol. 2020;11:578599.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7485471</ArticleId><ArticleId IdType="pubmed">32982760</ArticleId></ArticleIdList></Reference><Reference><Citation>Tagashira H, Bhuiyan MS, Shioda N, et al. Fluvoxamine rescues mitochondrial Ca2+ transport and ATP production through &#x3c3;1-receptor in hypertrophic cardiomyocytes. Life Sci. 2014;95(2):89&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pubmed">24373833</ArticleId></ArticleIdList></Reference><Reference><Citation>Braz GRF, Freitas CM, Nascimento L, et al. Neonatal SSRI exposure improves mitochondrial function and antioxidant defense in rat heart. Appl Physiol Nutr Metab. 2016;41(4):362&#x2013;369.</Citation><ArticleIdList><ArticleId IdType="pubmed">26939042</ArticleId></ArticleIdList></Reference><Reference><Citation>Tagashira H, Bhuiyan S, Shioda N, et al. &#x3c3;1-receptor stimulation with fluvoxamine ameliorates transverse aortic constriction-induced myocardial hypertrophy and dysfunction in mice. Am J Physiol Heart Circ Physiol. 2010;299(5):H1535&#x2013;H1545.</Citation><ArticleIdList><ArticleId IdType="pubmed">20802134</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdullah CS, Alam S, Aishwarya R, et al. Cardiac dysfunction in the sigma 1 receptor knockout mouse associated with impaired mitochondrial dynamics and bioenergetics. J Am Heart Assoc. 2018;7(20):e009775.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6474981</ArticleId><ArticleId IdType="pubmed">30371279</ArticleId></ArticleIdList></Reference><Reference><Citation>Safrany ST, Brimson JM. Are fluoxetine&#x2019;s effects due to sigma-1 receptor agonism? Pharmacol Res. 2016;113:707&#x2013;708.</Citation><ArticleIdList><ArticleId IdType="pubmed">27262678</ArticleId></ArticleIdList></Reference><Reference><Citation>Emilia M, Rosso D, Laura M, et al. Immunomodulatory effects of fluoxetine: a new potential pharmacological action for a classic antidepressant drug? Pharmacol Res. 2016;109:101&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pubmed">26644208</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulbins A, Schumacher F, Becker KA, et al. Antidepressants act by inducing autophagy controlled by sphingomyelin&#x2013;ceramide. Mol Psychiatry. 2018;23(12):2324&#x2013;2346.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6294742</ArticleId><ArticleId IdType="pubmed">30038230</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimniak M, Kirschner L, Hilpert H, et al. The serotonin reuptake inhibitor fluoxetine inhibits SARS-CoV-2 in human lung tissue. Sci Rep. 2021;11(1):1&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7961020</ArticleId><ArticleId IdType="pubmed">33723270</ArticleId></ArticleIdList></Reference><Reference><Citation>Dechaumes A, Nekoua MP, Belouzard S, et al. Fluoxetine can inhibit SARS-CoV-2 in vitro. Microorganisms. 2021;9(2):339.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7914627</ArticleId><ArticleId IdType="pubmed">33572117</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramakrishnan NK, Visser AK, Schepers M, et al. Dose-dependent sigma-1 receptor occupancy by donepezil in rat brain can be assessed with 11 C-SA4503 and microPET. Psychopharmacology (Berl). 2014;231(20):3997&#x2013;4006.</Citation><ArticleIdList><ArticleId IdType="pubmed">24639047</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishikawa M, Hashimoto K. The role of sigma-1 receptors in the pathophysiology of neuropsychiatric diseases. J Receptor Ligand Channel. 2010;3:25&#x2013;36.</Citation></Reference><Reference><Citation>Inagaki S, Funato M, Nakamura S, et al. Donepezil, an anti-Alzheimer&#x2019;s disease drug has the neuroprotective effect on RGCs derived from familial glaucoma patients&#x2019; iPS cells. Invest Ophthalmol Vis Sci. 2019;60(9):626.</Citation></Reference><Reference><Citation>Kim E, Park M, Jeong J, et al. Cholinesterase inhibitor donepezil increases mitochondrial biogenesis through AMP-activated protein kinase in the hippocampus. Neuropsychobiology. 2016;73(2):81&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">27002982</ArticleId></ArticleIdList></Reference><Reference><Citation>Khuanjing T, Palee S, Kerdphoo S, et al. Donepezil attenuated cardiac ischemia/reperfusion injury through balancing mitochondrial dynamics, mitophagy, and autophagy. Transl Res. 2021;230:82&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">33137536</ArticleId></ArticleIdList></Reference><Reference><Citation>Khuanjing T, Palee S, Chattipakorn S, et al. Acetylcholinesterase inhibitor protects against cardiac ischaemia/reperfusion injury via enhancing mitophagy and rebalancing mitochondrial dynamics. Eur Heart J. 2020;41(Supplement_2):ehaa946.3639.</Citation></Reference><Reference><Citation>Steardo L, Monteleone P, d&#x2019;Istria M, et al. Sigma receptor modulation of noradrenergic-stimulated pineal melatonin biosynthesis in rats. J Neurochem. 1996. Jul;67(1):287&#x2013;293.</Citation><ArticleIdList><ArticleId IdType="pubmed">8667004</ArticleId></ArticleIdList></Reference><Reference><Citation>Pourhanifeh MH, Dehdashtian E, Hosseinzadeh A, et al. Clinical application of melatonin in the treatment of cardiovascular diseases: current evidence and new insights into the cardioprotective and cardiotherapeutic properties. Cardiovasc Drugs Ther. 2020;1&#x2013;25. DOI:10.1007/s10557-020-07052-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10557-020-07052-3</ArticleId><ArticleId IdType="pubmed">32926271</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehrzadi S, Karimi MY, Fatemi A, et al. SARS-CoV-2 and other coronaviruses negatively influence mitochondrial quality control: beneficial effects of melatonin. Pharmacol Ther. 2021. Jul;224:107825.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7919585</ArticleId><ArticleId IdType="pubmed">33662449</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirata Y, Yamamoto H, Atta MSM, et al. Chloroquine inhibits glutamate&#x2010;induced death of a neuronal cell line by reducing reactive oxygen species through sigma&#x2010;1 receptor. J Neurochem. 2011;119(4):839&#x2013;847.</Citation><ArticleIdList><ArticleId IdType="pubmed">21883227</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao X, Ye F, Zhang M, et al. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2). Clinl Infect Dis. 2020;71(15):732&#x2013;739.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7108130</ArticleId><ArticleId IdType="pubmed">32150618</ArticleId></ArticleIdList></Reference><Reference><Citation>Echeverr&#xed;a-Esnal D, Martin-Ontiyuelo C, Navarrete-Rouco ME, et al. Azithromycin in the treatment of COVID-19: a review. Expert Rev Anti Infect Ther. 2021. February 01;19(2):147&#x2013;163.</Citation><ArticleIdList><ArticleId IdType="pubmed">32853038</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu M, Caputi TL, Dredze M, et al. Internet searches for unproven COVID-19 therapies in the United States. JAMA Intern Med. 2020;180(8):1116&#x2013;1118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7191468</ArticleId><ArticleId IdType="pubmed">32347895</ArticleId></ArticleIdList></Reference><Reference><Citation>Horby P, Mafham M, Linsell L, et al. Effect of hydroxychloroquine in hospitalized patients with Covid-19. N Engl J Med. 2020;383(21):2030&#x2013;2040.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7556338</ArticleId><ArticleId IdType="pubmed">33031652</ArticleId></ArticleIdList></Reference><Reference><Citation>Geleris J, Sun Y, Platt J, et al. Observational study of hydroxychloroquine in hospitalized patients with Covid-19. N Engl J Med. 2020;382(25):2411&#x2013;2418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7224609</ArticleId><ArticleId IdType="pubmed">32379955</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z, Hu J, Zhang Z, et al. Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial. United States: medrxiv. Preprint;2020. doi:10.1101/2020.03.22.20040758.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.03.22.20040758</ArticleId></ArticleIdList></Reference><Reference><Citation>Mah&#xe9;vas M, Tran V-T, Roumier M, et al. Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data. BMJ. 2020;369:m1844.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7221472</ArticleId><ArticleId IdType="pubmed">32409486</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenberg ES, Dufort EM, Udo T, et al. Association of treatment with hydroxychloroquine or azithromycin with in-hospital mortality in patients with COVID-19 in New York State. JAMA. 2020;323(24):2493&#x2013;2502.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7215635</ArticleId><ArticleId IdType="pubmed">32392282</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehra MR, Ruschitzka F, Patel AN. Retraction-hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. Lancet. 2020;395(10240):1820.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7274621</ArticleId><ArticleId IdType="pubmed">32511943</ArticleId></ArticleIdList></Reference><Reference><Citation>Berardi F, Abate C, Ferorelli S, et al. 1-Cyclohexylpiperazine and 3, 3-Dimethylpiperidine derivatives as sigma-1 (sig1) and sigma-2 (sig2) receptor ligands: a review. Central Nervous System Agents Med Chem. 2009;9(3):205&#x2013;219.</Citation><ArticleIdList><ArticleId IdType="pubmed">20021355</ArticleId></ArticleIdList></Reference><Reference><Citation>Abate C, Niso M, Abatematteo FS, et al. PB28, the sigma-1 and sigma-2 receptors modulator with potent anti&#x2013;SARS-CoV-2 activity: a review about its pharmacological properties and structure affinity relationships. Front Pharmacol. 2020;11. DOI:10.3389/fphar.2020.589810.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.589810</ArticleId><ArticleId IdType="pmc">PMC7750835</ArticleId><ArticleId IdType="pubmed">33364961</ArticleId></ArticleIdList></Reference><Reference><Citation>Benvenuto D, Angeletti S, Giovanetti M, et al. Evolutionary analysis of SARS-CoV-2: how mutation of non-structural protein 6 (NSP6) could affect viral autophagy. J Infect. 2020;81(1):e24&#x2013;e27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7195303</ArticleId><ArticleId IdType="pubmed">32283146</ArticleId></ArticleIdList></Reference><Reference><Citation>Colabufo NA, Leopoldo M, Ferorelli S, et al. Why PB28 could be a Covid 2019 game changer? ACS Med Chem Lett. 2020;11(10):2048&#x2013;2050.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7437449</ArticleId><ArticleId IdType="pubmed">33052254</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandey P, Prasad K, Prakash A, et al. Insights into the biased activity of dextromethorphan and haloperidol towards SARS-CoV-2 NSP6: in silico binding mechanistic analysis. J Mol Med. 2020;98(12):1659&#x2013;1673.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7509052</ArticleId><ArticleId IdType="pubmed">32965508</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoertel N, S&#xe1;nchez-Rico M, Vernet R, et al. Observational study of haloperidol in hospitalized patients with COVID-19. PloS One. 2021;16(2):e0247122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7895415</ArticleId><ArticleId IdType="pubmed">33606790</ArticleId></ArticleIdList></Reference><Reference><Citation>Su T-P, Hayashi T. Understanding the molecular mechanism of sigma-1 receptors: towards a hypothesis that sigma-1 receptors are intracellular amplifiers for signal transduction. Curr Med Chem. 2003;10(20):2073&#x2013;2080.</Citation><ArticleIdList><ArticleId IdType="pubmed">12871086</ArticleId></ArticleIdList></Reference><Reference><Citation>Plaze M, Attali D, Prot M, et al. Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine. Int J Antimicrob Agents. 2021;57(3):106274.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7772996</ArticleId><ArticleId IdType="pubmed">33387629</ArticleId></ArticleIdList></Reference><Reference><Citation>Belani P, Schefflein J, Kihira S, et al. COVID-19 is an independent risk factor for acute ischemic stroke. Am J Neuroradiol. 2020;41(8):1361&#x2013;1364.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7658882</ArticleId><ArticleId IdType="pubmed">32586968</ArticleId></ArticleIdList></Reference><Reference><Citation>Fridman S, Bullrich MB, Jimenez-Ruiz A, et al. Stroke risk, phenotypes, and death in COVID-19: systematic review and newly reported cases. Neurology. 2020;95(24):e3373&#x2013;e3385.</Citation><ArticleIdList><ArticleId IdType="pubmed">32934172</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia J, Cheng J, Wang C, et al. Sigma-1 receptor-modulated neuroinflammation in neurological diseases [mini review]. Front Cell Neurosci. 2018. September 20;12(314). DOI:10.3389/fncel.2018.00314.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2018.00314</ArticleId><ArticleId IdType="pmc">PMC6158303</ArticleId><ArticleId IdType="pubmed">30294261</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen YC, Wang YH, Chou YC, et al. Dimemorfan protects rats against ischemic stroke through activation of sigma&#x2010;1 receptor&#x2010;mediated mechanisms by decreasing glutamate accumulation. J Neurochem. 2008;104(2):558&#x2013;572.</Citation><ArticleIdList><ArticleId IdType="pubmed">18173806</ArticleId></ArticleIdList></Reference><Reference><Citation>Allahtavakoli M, Jarrott B. Sigma-1 receptor ligand PRE-084 reduced infarct volume, neurological deficits, pro-inflammatory cytokines and enhanced anti-inflammatory cytokines after embolic stroke in rats. Brain Res Bull. 2011;85(3&#x2013;4):219&#x2013;224.</Citation><ArticleIdList><ArticleId IdType="pubmed">21453760</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazur A, Fangman M, Ashouri R, et al. Nrf2 as a therapeutic target in ischemic stroke. Expert Opin Ther Targets. 2021. March 04;25(3):163&#x2013;166.</Citation><ArticleIdList><ArticleId IdType="pubmed">33648411</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasanth MI, Tencomnao T, Brimson JM. Letter to the editor, the sigma-1 receptors role in neuroprotection: comment on Nrf2 as a therapeutic target in ischemic stroke. Expert Opinion on Therapeutic Targets. 2021; Online ahead of print. doi.10.1080/14728222.2021.1948016</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14728222.2021.1948016</ArticleId><ArticleId IdType="pubmed">34180350</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe1;nchez-Bl&#xe1;zquez P, Pozo-Rodrig&#xe1;lvarez A, Merlos M, et al. The sigma-1 receptor antagonist, S1RA, reduces stroke damage, ameliorates post-stroke neurological deficits and suppresses the overexpression of MMP-9. Mol Neurobiol. 2018. June 01;55(6):4940&#x2013;4951.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5948242</ArticleId><ArticleId IdType="pubmed">28779350</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg RK, Paliwal VK, Gupta A. Encephalopathy in patients with COVID&#x2010;19: a review. J Med Virol. 2020;93(1):206&#x2013;222.</Citation><ArticleIdList><ArticleId IdType="pubmed">32558956</ArticleId></ArticleIdList></Reference><Reference><Citation>Bougakov D, Podell K, Goldberg E. Multiple neuroinvasive pathways in COVID-19. Mol Neurobiol. 2021;58(2):564&#x2013;575.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7523266</ArticleId><ArticleId IdType="pubmed">32990925</ArticleId></ArticleIdList></Reference><Reference><Citation>Hascup ER, Hascup KN. Does SARS-CoV-2 infection cause chronic neurological complications? GeroScience. 2020;42(4):1083&#x2013;1087.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7247778</ArticleId><ArticleId IdType="pubmed">32451846</ArticleId></ArticleIdList></Reference><Reference><Citation>Desforges M, Le Coupanec A, Dubeau P, et al. Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? Viruses. 2020;12(1):14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7020001</ArticleId><ArticleId IdType="pubmed">31861926</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciaccio M, Lo Sasso B, Scazzone C, et al. COVID-19 and Alzheimer&#x2019;s disease. Brain Sci. 2021;11(3):305.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7997244</ArticleId><ArticleId IdType="pubmed">33673697</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammadi S, Moosaie F, Aarabi MH. Understanding the immunologic characteristics of neurologic manifestations of SARS-CoV-2 and potential immunological mechanisms. Mol Neurobiol. 2020;57(12):5263&#x2013;5275.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7458880</ArticleId><ArticleId IdType="pubmed">32869183</ArticleId></ArticleIdList></Reference><Reference><Citation>Coolen T, Lolli V, Sadeghi N, et al. Early postmortem brain MRI findings in COVID-19 non-survivors. Neurology. 2020;95(14):e2016&#x2013;e2027.</Citation><ArticleIdList><ArticleId IdType="pubmed">32546654</ArticleId></ArticleIdList></Reference><Reference><Citation>Reichard RR, Kashani KB, Boire NA, et al. Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology. Acta Neuropathol. 2020;140(1):1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7245994</ArticleId><ArticleId IdType="pubmed">32449057</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacomy H, Fragoso G, Almazan G, et al. Human coronavirus OC43 infection induces chronic encephalitis leading to disabilities in BALB/C mice. Virology. 2006;349(2):335&#x2013;346.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7111850</ArticleId><ArticleId IdType="pubmed">16527322</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y, Li X, Geng D, et al. Cerebral micro-structural changes in COVID-19 patients&#x2013;an MRI-based 3-month follow-up study. EClinicalMedicine. 2020;25:100484.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7396952</ArticleId><ArticleId IdType="pubmed">32838240</ArticleId></ArticleIdList></Reference><Reference><Citation>Love S, Miners JS. Cerebrovascular disease in ageing and Alzheimer&#x2019;s disease. Acta Neuropathol. 2016;131(5):645&#x2013;658.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4835514</ArticleId><ArticleId IdType="pubmed">26711459</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo L, Tan R-X. Fluoxetine inhibits dendrite atrophy of hippocampal neurons by decreasing nitric oxide synthase expression in rat depression model. Acta Pharmacol Sin. 2001;22(10):865&#x2013;870.</Citation><ArticleIdList><ArticleId IdType="pubmed">11749766</ArticleId></ArticleIdList></Reference><Reference><Citation>Santarelli L, Saxe M, Gross C, et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. science. 2003;301(5634):805&#x2013;809.</Citation><ArticleIdList><ArticleId IdType="pubmed">12907793</ArticleId></ArticleIdList></Reference><Reference><Citation>Soscia SJ, Kirby JE, Washicosky KJ, et al. The Alzheimer&#x2019;s disease-associated amyloid &#x3b2;-protein is an antimicrobial peptide. PloS One. 2010;5(3):e9505.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2831066</ArticleId><ArticleId IdType="pubmed">20209079</ArticleId></ArticleIdList></Reference><Reference><Citation>Tipton PW, Wszolek ZK. What can Parkinson&#x2019;s disease teach us about COVID-19? Neurol Neurochir Pol. 2020;54(2):204&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pubmed">32323862</ArticleId></ArticleIdList></Reference><Reference><Citation>Francardo V. Sigma-1 receptor: a potential new target for Parkinson&#x2019;s disease? Neural Regen Res. 2014;9(21):1882.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4281425</ArticleId><ArticleId IdType="pubmed">25558236</ArticleId></ArticleIdList></Reference><Reference><Citation>Francardo V, Geva M, Bez F, et al. Pridopidine induces functional neurorestoration via the sigma-1 receptor in a mouse model of Parkinson&#x2019;s disease. Neurotherapeutics. 2019;16(2):465&#x2013;479.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6554374</ArticleId><ArticleId IdType="pubmed">30756361</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo C-H, Cao T, Zheng L-T, et al. Development and characterization of an inducible Dicer conditional knockout mouse model of Parkinson&#x2019;s disease: validation of the antiparkinsonian effects of a sigma-1 receptor agonist and dihydromyricetin. Acta Pharmacol Sin. 2020;41(4):499&#x2013;507.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7468551</ArticleId><ArticleId IdType="pubmed">32112040</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishina M, Ishiwata K, Ishii K, et al. Function of sigma 1 receptors in Parkinson&#x2019;s disease. Acta Neurol Scand. 2005;112(2):103&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pubmed">16008536</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori T, Hayashi T, Su TP. Compromising &#x3c3;-1 receptors at the endoplasmic reticulum render cytotoxicity to physiologically relevant concentrations of dopamine in a nuclear factor-&#x3ba;B/Bcl-2-dependent mechanism: potential relevance to Parkinson&#x2019;s disease. J Pharmacol Exp Ther. 2012;341(3):663&#x2013;671.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3362887</ArticleId><ArticleId IdType="pubmed">22399814</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahorsu DK, Lin CY, Imani V, et al. The fear of COVID-19 scale: development and initial validation. Int J Ment Health Addict. 2020;27:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7100496</ArticleId><ArticleId IdType="pubmed">32226353</ArticleId></ArticleIdList></Reference><Reference><Citation>Mamun MA, Ullah I. COVID-19 suicides in Pakistan, dying off not COVID-19 fear but poverty? - The forthcoming economic challenges for a developing country. Brain Behav Immun. 2020. Jul;87:163&#x2013;166.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7212955</ArticleId><ArticleId IdType="pubmed">32407859</ArticleId></ArticleIdList></Reference><Reference><Citation>Troyer EA, Kohn JN, Hong S. Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms. Brain Behav Immun. 2020. Jul;87:34&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7152874</ArticleId><ArticleId IdType="pubmed">32298803</ArticleId></ArticleIdList></Reference><Reference><Citation>Bermack JE, Debonnel G. The role of sigma receptors in depression. J Pharmacol Sci. 2005;336:317&#x2013;336.</Citation><ArticleIdList><ArticleId IdType="pubmed">15750289</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabino V, Cottone P, Parylak SL, et al. Sigma-1 receptor knockout mice display a depressive-like phenotype. Behav Brain Res. 2009;198(2):472&#x2013;476.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2667953</ArticleId><ArticleId IdType="pubmed">19100292</ArticleId></ArticleIdList></Reference><Reference><Citation>Celano CM, Millstein RA, Bedoya CA, et al. Association between anxiety and mortality in patients with coronary artery disease: a meta-analysis. Am Heart J. 2015;170(6):1105&#x2013;1115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4684590</ArticleId><ArticleId IdType="pubmed">26678632</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker ER, McGee RE, Druss BG. Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis. JAMA Psychiatry. 2015;72(4):334&#x2013;341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4461039</ArticleId><ArticleId IdType="pubmed">25671328</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilman SE, Sucha E, Kingsbury M, et al. Depression and mortality in a longitudinal study: 1952-2011. CMAJ. 2017;189(42):E1304&#x2013;E1310.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5654987</ArticleId><ArticleId IdType="pubmed">29061855</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuijpers P, Vogelzangs N, Twisk J, et al. Comprehensive meta-analysis of excess mortality in depression in the general community versus patients with specific illnesses. Am J Psychiatry. 2014. Apr;171(4):453&#x2013;462.</Citation><ArticleIdList><ArticleId IdType="pubmed">24434956</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashimoto K. Sigma-1 receptor chaperone and brain-derived neurotrophic factor: emerging links between cardiovascular disease and depression. Prog Neurobiol. 2013;100:15&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">23044468</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito K, Hirooka Y, Matsukawa R, et al. Decreased brain sigma-1 receptor contributes to the relationship between heart failure and depression. Cardiovasc Res. 2012;93(1):33&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">21960687</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao F, Tan W, Jiang L, et al. Do psychiatric patients experience more psychiatric symptoms during COVID-19 pandemic and lockdown? A case-control study with service and research implications for immunopsychiatry. Brain Behav Immun. 2020;87:100&#x2013;106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7184991</ArticleId><ArticleId IdType="pubmed">32353518</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L, Li F, Fortunati F, et al. Association of a prior psychiatric diagnosis with mortality among hospitalized patients with coronavirus disease 2019 (COVID-19) infection. JAMA Network Open. 2020;3(9):e2023282&#x2013;e2023282.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7527869</ArticleId><ArticleId IdType="pubmed">32997123</ArticleId></ArticleIdList></Reference><Reference><Citation>Lega I, Nistic&#xf2; L, Palmieri L, et al. Psychiatric disorders among hospitalized patients deceased with COVID-19 in Italy. EClinicalMedicine. 2021. Apr;23:100854.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8062162</ArticleId><ArticleId IdType="pubmed">33907730</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Luciano S, Geddes JR, et al. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62&#x2008;354 COVID-19 cases in the USA. Lancet Psychiatry. 2021. Feb;8(2):130&#x2013;140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7820108</ArticleId><ArticleId IdType="pubmed">33181098</ArticleId></ArticleIdList></Reference><Reference><Citation>Alyami HS, Naser AY, Dahmash EZ, et al. Depression and anxiety during the COVID-19 pandemic in Saudi Arabia: a cross-sectional study. Int J Clin Pract. 2021;20:e14244.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8249996</ArticleId><ArticleId IdType="pubmed">33876864</ArticleId></ArticleIdList></Reference><Reference><Citation>Holt-Lunstad J, Smith TB, Baker M, et al. Loneliness and social isolation as risk factors for mortality: a meta-analytic review. Perspect Psychol Sci. 2015. Mar;10(2):227&#x2013;237.</Citation><ArticleIdList><ArticleId IdType="pubmed">25910392</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner MH, Bhugra D. Acceleration of anxiety, depression, and suicide: secondary effects of economicdisruption related to COVID-19. Front Psychiatry. 2020;11:592467.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7771384</ArticleId><ArticleId IdType="pubmed">33384627</ArticleId></ArticleIdList></Reference><Reference><Citation>Salari N, Hosseinian-Far A, Jalali R, et al. Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: a systematic review and meta-analysis. Global Health. 2020. Jul 6;16(1):57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7338126</ArticleId><ArticleId IdType="pubmed">32631403</ArticleId></ArticleIdList></Reference><Reference><Citation>Couly S, Goguadze N, Yasui Y, et al. Knocking out sigma-1 receptors reveals diverse health problems. Cell Mol Neurobiol. 2020. Oct:1&#x2013;24. DOI:10.1007/s10571-020-00983-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-020-00983-3</ArticleId><ArticleId IdType="pmc">PMC8062587</ArticleId><ArticleId IdType="pubmed">33095392</ArticleId></ArticleIdList></Reference><Reference><Citation>Caramelo F, Ferreira N, Oliveiros B. Estimation of risk factors for COVID-19 mortality-preliminary results. United States:MedRxiv. Preprint; 2020. DOI:10.1101/2020.02.24.20027268.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.02.24.20027268</ArticleId></ArticleIdList></Reference><Reference><Citation>Kourrich S, Su T-P, Fujimoto M, et al. The sigma-1 receptor: roles in neuronal plasticity and disease. Trends Neurosci. 2012;35(12):1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3587126</ArticleId><ArticleId IdType="pubmed">23102998</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>